Mammen P. Anza Mammen
Senior Vice President, Clinical Development
Mammen P. “Anza” Mammen, Jr., M.D., joined us as Vice President, Clinical Vaccines in November 2012 and was named Senior Vice President, Clinical Development in May 2017. Prior to joining Vical, Dr. Mammen retired as a colonel after a 21-year career in the Army Medical Corps, most recently as Infectious Disease Consultant and Chief, Pandemic Warning Team, U.S. Department of Defense. From 2006 to 2010, he served as the Army’s Product Manager for vaccines in Advanced Development against dengue, hepatitis E, and HIV viruses for the U.S. Army Medical Research and Materiel Command (USAMRMC). He was Chief, Department of Virology, the Armed Forces Research Institute of Medical Sciences (AFRIMS), Thailand, from 2001 to 2006 when he managed U.S. Food and Drug Administration-regulated vaccine field studies. His previous assignments include serving as Infectious Disease Officer, Walter Reed Army Institute of Research (WRAIR), and Chief, Internal Medicine Clinic, 121st General Hospital, Seoul, South Korea. Dr. Mammen received his M.D. degree from the Pennsylvania State University College of Medicine and is Board-certified in Infectious Diseases. He has been elected as Fellow by the Infectious Disease Society of America (IDSA) and the American College of Physicians (ACP). He received his Internal Medicine and Infectious Disease clinical training from the Walter Reed Army Medical Center. He earned a B.A. degree in mathematics from Williams College.